SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,472.33 879.09
( 1.23%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.5541002

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

52.63

34.75

EPS(TTM)

Face Value()

Div & Yield %

0.46

Back

prolife industries ltd

Accelya Solutions India consolidated net profit declines 29.32% in the March 2026 quarter

Apr 29,2026

Net profit of Accelya Solutions India declined 29.32% to Rs 21.38 crore in the quarter ended March 2026 as against Rs 30.25 crore during the previous quarter ended March 2025. Sales declined 0.47% to Rs 136.05 crore in the quarter ended March 2026 as against Rs 136.69 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	136.05	136.69	0
OPM %	25.28	33.92	-
PBDT	44.10	48.20	-9
PBT	29.53	41.73	-29
NP	21.38	30.25	-29

72,472.33 879.09 ( 1.23%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)